Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 6, 2025 • 10:51 AM ET

Date/Time Source News Release
03/16/2021 07:30 AM EDT GlobeNewswire Mydecine Innovations Group Provides Update on European Operations
03/15/2021 10:44 PM EDT Business Wire Mydecine Announces Change of Auditor
03/10/2021 07:30 AM EST GlobeNewswire Mydecine Innovations Group Announces Plans to Spin Out of its [U.S.] Cannabis Assets
03/01/2021 07:30 AM EST GlobeNewswire Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain
02/24/2021 07:00 AM EST GlobeNewswire Mydecine Announces Exclusive Partnership and Increased Capabilities with Applied Pharmaceutical Innovation (API) at the University of Alberta
02/17/2021 07:00 AM EST GlobeNewswire Mydecine Innovations Group Announces Filing of a Provisional Patent for Mindleap's Mental Health Technology
02/12/2021 09:08 AM EST Business Wire Mydecine Innovations Group Announces Closing of $17,250,000 Bought-Deal Public Offering, Including Full Exercise of the Over-Allotment Option
02/09/2021 02:29 PM EST Business Wire Mydecine Innovations Group Files Final Prospectus in Connection with Bought Deal Offering of Units
02/05/2021 08:06 AM EST Business Wire Mydecine Innovations Group Files Amended and Restated Financial Statements
02/03/2021 07:30 AM EST GlobeNewswire Mydecine Innovations Group Appoints Josephine Wu to Board of Directors
Page